Senior Clinical Research Associate

vor 4 Wochen

Tübingen, Baden-Württemberg, Deutschland Immatics Biotechnologies GmbH Vollzeit

Immatics combines the discovery of true targets for cancer immunotherapies with the development of the right T cell receptors with the goal of enabling a robust and specific T cell response against these targets.

This deep know-how is the foundation for our pipeline of Adoptive Cell Therapies and TCR Bispecifics as well as our partnerships with global leaders in the pharmaceutical industry .

click apply for full job details

  • Account Manager

    vor 3 Wochen

    Tübingen, Baden-Württemberg, Deutschland Danaher Vollzeit

    Be part of something altogether life-changingWorking at Cytiva means being at the forefront of providing new solutions to transform human health. Our incredible customers undertake life-saving activities ranging from fundamental biological research to developing innovative vaccines, new medicines, and cell and gene therapies.At Cytiva you will be able to...

  • (Senior) Director

    vor 1 Monat

    Tübingen, Deutschland CureVac Vollzeit

    CureVac Manufacturing GmbH, a wholly owned subsidiary of CureVac SE, is a biopharmaceutical company producing novel drugs based on the natural molecule Messenger RNA (mRNA). Our focus is on innovative cancer immunotherapies, prophylactic vaccines and molecular therapies. Currently, all RNA people are striving to achieve our main goal: To bring multiple...

  • (Associate) Director SAP

    vor 1 Monat

    Tübingen, Deutschland CureVac Vollzeit

    CureVac Corporate Services GmbH, a wholly owned subsidiary of CureVac SE, combines the central functions of the CureVac business group. CureVac is a global biopharmaceutical company in the field of mRNA technology, with more than 20 years of expertise in researching, developing and optimizing the versatile biological molecule for medical purposes. Our focus...

  • Senior Digital

    vor 1 Monat

    Tübingen, Deutschland CureVac Vollzeit

    CureVac Corporate Services GmbH, a wholly owned subsidiary of CureVac SE, combines the central functions of the CureVac business group. CureVac is a global biopharmaceutical company in the field of mRNA technology, with more than 20 years of expertise in researching, developing and optimizing the versatile biological molecule for medical purposes. Our focus...